Schmieder R (2015)
Publication Type: Journal article, Review article
Publication year: 2015
Book Volume: 22 Suppl 1
Pages Range: 11-3
DOI: 10.1007/s40292-015-0098-z
Treatment-resistant hypertension (TRH) has a prevalence of approximately 10-20 %, and up to 5 % of patients with TRH experience a major cardiovascular or cerebrovascular event each year. Effective management of real TRH is important but can present a significant clinical challenge. Utilisation of treatment options that maximise treatment compliance is recommended, particularly combinations that have supporting data from clinical studies. Renal denervation can be considered for a subset of truly resistant patients.
APA:
Schmieder, R. (2015). Managing Treatment-Resistant Patients. High Blood Pressure and Cardiovascular Prevention, 22 Suppl 1, 11-3. https://doi.org/10.1007/s40292-015-0098-z
MLA:
Schmieder, Roland. "Managing Treatment-Resistant Patients." High Blood Pressure and Cardiovascular Prevention 22 Suppl 1 (2015): 11-3.
BibTeX: Download